null

Guselkumab (Anti-IL23A) Biosimilar Antibody

SKU:
HDBS0146
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
IL-23A
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Guselkumab (Anti-IL23A) Biosimilar Antibody (HDBS0146)

The Guselkumab Biosimilar Anti-IL23A Antibody is a cutting-edge product designed for researchers studying interleukin-23 (IL-23) in immune regulation. This monoclonal antibody targets IL-23A, a key cytokine involved in inflammatory responses and autoimmune diseases. The antibody is produced using advanced biosimilar technology, ensuring high specificity and sensitivity in binding to IL-23A.Ideal for use in ELISA, Western blot, and immunohistochemistry applications, the Guselkumab Biosimilar Anti-IL23A Antibody enables precise detection and quantification of IL-23A in various sample types. Its unique ability to neutralize IL-23A activity makes it a valuable tool for investigating the role of IL-23A in diseases such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis.

With its proven efficacy and reliability, the Guselkumab Biosimilar Anti-IL23A Antibody is a must-have for researchers seeking to deepen their understanding of IL-23A signaling pathways and develop novel therapeutic approaches targeting IL-23A-mediated immune dysregulation. Invest in this innovative antibody today and accelerate your research progress in the field of immunology and autoimmune disorders.